These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 19127583)
1. Future of cell and gene therapies for Parkinson's disease. Isacson O; Kordower JH Ann Neurol; 2008 Dec; 64 Suppl 2(0 2):S122-38. PubMed ID: 19127583 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Parkinson's disease : what's on the horizon? Wu SS; Frucht SJ CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989 [TBL] [Abstract][Full Text] [Related]
3. Models of repair mechanisms for future treatment modalities of Parkinson's disease. Isacson O Brain Res Bull; 2002 Apr; 57(6):839-46. PubMed ID: 12031282 [TBL] [Abstract][Full Text] [Related]
4. Current disease modifying approaches to treat Parkinson's disease. Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. Fernandez-Espejo E Mol Neurobiol; 2004 Feb; 29(1):15-30. PubMed ID: 15034220 [TBL] [Abstract][Full Text] [Related]
6. Repairing the parkinsonian brain with neurotrophic factors. Aron L; Klein R Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600 [TBL] [Abstract][Full Text] [Related]
7. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review. Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171 [TBL] [Abstract][Full Text] [Related]
8. Gene transfer techniques for the delivery of GDNF in Parkinson's disease. Ridet JL; Déglon N; Aebischer P Novartis Found Symp; 2000; 231():202-15; discussion 215-9, 302-6. PubMed ID: 11131539 [TBL] [Abstract][Full Text] [Related]
9. Future and current surgical therapies in Parkinson's disease. Betchen SA; Kaplitt M Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808 [TBL] [Abstract][Full Text] [Related]
10. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease. Tereshchenko J; Maddalena A; Bähr M; Kügler S Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. Liu WG; Lu GQ; Li B; Chen SD Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309 [TBL] [Abstract][Full Text] [Related]
13. Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We? Buttery PC; Barker RA Neurotherapeutics; 2020 Oct; 17(4):1539-1562. PubMed ID: 33128174 [TBL] [Abstract][Full Text] [Related]
14. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)]. Mínguez-Castellanos A; Escamilla-Sevilla F Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638 [TBL] [Abstract][Full Text] [Related]
15. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease. Kordower JH Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104 [TBL] [Abstract][Full Text] [Related]
17. Regenerative medicine for Parkinson's disease. Yasuhara T; Kameda M; Agari T; Date I Neurol Med Chir (Tokyo); 2015; 55(2):113-23. PubMed ID: 25746305 [TBL] [Abstract][Full Text] [Related]